News | EP Lab | May 09, 2017

Pure EP Recording System Reviewed Journal of Innovations in Cardiac Rhythm Management

BioSig Pure EP Signal Recording System

May 9, 2017 — A manuscript by physicians from Mayo Clinic and Harvard Brigham & Women's Hospital entitled, “Initial Experience with the BioSig Pure EP Signal Recording System: An Animal Laboratory Experience,” was published in The Journal of Innovations in Cardiac Rhythm Management (JICRM), April 2017 issue. Read the article by clicking here.

Initial results and solutions offered by the Pure EP System are highlighted in several main categories:

• Saturation artifact
• Clipping/Overlapping of signals
• Noise due to ablation
• Unipolar signals
• Contact force
• Poor catheter visualization
• Conduction tissue signal recording

“BioSig is very grateful to collaborate with key opinion leaders in the EP field,” said BioSig Executive Chairman Kenneth Londoner “This collaboration, together with preclinical data derived from studies conducted from 2015 to date, have produced very significant results to help the Company strengthen its positioning statement for the Pure EP System. The findings in this publication clearly show the need for expanding the boundaries in recording cardiac signals in the electrophysiology lab. Our system demonstrated abilities to produce great recordings from legacy catheters (Boston Scientific and Johnson & Johnson) and enhanced recordings compared to existing recording and mapping systems. One of the most important findings is Pure EP System’s ability to record high quality unipolar signals and current of injury (COI), which can complement data obtained using a contact force-sensing catheter.”

For more information: www.biosigtech.com

Related Content

 ElectroSonix
News | EP Lab | December 30, 2019
December 30, 2019 — Acoustoelectric cardiac imaging, a new, noninvasive cardiac imaging technology developed at the U
Peter_Weiss, M.D., explains a Stereotaxis robotically navigated cardiac ablation procedure at Banner University Medicine Heart Institute.

Peter_Weiss, M.D., explains a Stereotaxis robotically navigated cardiac ablation procedure at Banner University Medicine Heart Institute.

Feature | EP Lab | December 23, 2019 | J. Peter Weiss, M.D., MSc
Robotic technology, which helps carry out repetitive tasks efficiently and precisely, has been gaining ground in...
Earlier this year, Medtronic began a worldwide pivotal study evaluating its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system to treat dangerously fast heart rhythms. The EV ICD system is designed to deliver lifesaving defibrillation and pacing therapy via a device the same size as traditional, transvenous ICDs, but with a lead (thin wire) placed outside the heart and veins. The future of CRM device technology.

Earlier this year, Medtronic began a worldwide pivotal study evaluating its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system to treat dangerously fast heart rhythms. The EV ICD system is designed to deliver lifesaving defibrillation and pacing therapy via a device the same size as traditional, transvenous ICDs, but with a lead (thin wire) placed outside the heart and veins.

Feature | EP Lab | November 11, 2019 | Hrishikesh Kadam
Cardiac rhythm management (CRM) devices in use today are evolving to raise the bar beyond monitoring and managing car
A comparison between the EPstar 2F and 6F catheters from Baylis. Electrophysiology catheters. EP lab

A comparison between the EPstar 2F and 6F catheters from Baylis.

News | EP Lab | October 31, 2019
October 31, 2019 — Baylis Medical announced the first North American use of its EPstar Fixed...
New Study Shows Chronic Epilepsy Associated With Marker of Cardiac Electrical Instability
News | EP Lab | October 24, 2019
LivaNova PLC announced the publication of a new study in Neurology, which suggests that chronic epilepsy may be...
Lenox Hill Hospital Opens New Heart Rhythm Center
News | EP Lab | August 27, 2019
Lenox Hill Hospital (New York, N.Y.) has established a brand new Heart Rhythm Center dedicated to the treatment of...
Damaged Hearts Rewired With Nanotube Fibers

Researchers at Texas Heart Institute and Rice University have confirmed that flexible, conductive fibers made of carbon nanotubes can bridge damaged tissue to deliver electrical signals and keep hearts beating despite congestive heart failure or dilated cardiomyopathy or after a heart attack. Image courtesy of Texas Heart Institute.

News | EP Lab | August 15, 2019
Thin, flexible fibers made of carbon nanotubes have now proven able to bridge damaged heart tissues and deliver the...
Cardiac Device Complications Vary Widely Among Hospitals
News | EP Lab | July 31, 2019
The chances of patients experiencing complications after having a cardiac device implanted vary according to where they...
Overlay Init